本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pliant Therapeutics, Inc.

1.12
0.0000
成交量:46.19萬
成交額:52.47萬
市值:6,934.44萬
市盈率:-0.75
高:1.17
開:1.12
低:1.10
收:1.12
52周最高:1.95
52周最低:1.02
股本:6,191.47萬
流通股本:5,503.36萬
量比:1.67
換手率:0.84%
股息:- -
股息率:- -
每股收益(TTM):-1.5000
每股收益(LYR):-2.4336
淨資產收益率:-50.29%
總資產收益率:-23.27%
市淨率:0.47
市盈率(LYR):-0.46

資料載入中...

2021/03/16

重要事件披露

8-K - Current report
2021/03/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

重要事件披露

8-K - Current report
2020/12/21

重要事件披露

8-K - Current report
2020/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

重要事件披露

8-K - Current report
2020/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/11

重要事件披露

8-K - Current report
2020/07/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/09

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/02

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/05/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/29

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/26

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933